[1]
Bertelsen, A. et al. 2012. Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? – A planning study. Acta Oncologica. 51, 6 (Jul. 2012), 752–758. DOI:https://doi.org/10.3109/0284186X.2011.648341.